Rasagiline

In the US, Rasagiline (rasagiline systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease.

US matches:

• Rasagiline


• Rasagiline Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

N04BD02

CAS registry number (Chemical Abstracts Service)

0136236-51-6

Chemical Formula

C12-H13-N

Molecular Weight

171

Therapeutic Categories

Treatment of Parkinson's disease

Inhibitor of monoamin oxidase type B (MAO-B)

Chemical Names

(R)-N-2-propynyl-1-indanamine

N-propargyl-1-(R)-aminoindan

Foreign Names

• Rasagilinum (Latin)
• Rasagilin (German)
• Rasagiline (French)
• Rasagilina (Spanish)

Generic Names

• Rasagiline mesylate (OS: USAN)
• AGN-1135 (IS)
• Rasagiline methanesulfonate (IS)
• TVP 1012 (IS: Teva)
• TVP-101 (IS)

Brand Names

• Azilect
  Teva, Bulgaria; Teva, Russian Federation; Teva, Slovakia; Key Oncologics, South Africa; Lundbeck, Belgium; Lundbeck, Switzerland; Lundbeck, Germany; Lundbeck, Spain; Lundbeck, Finland; Lundbeck, France; Lundbeck, Croatia (Hrvatska); Lundbeck, Ireland; Lundbeck, Italy; Lundbeck, Sweden; Lundbeck, Turkey; Teva, Austria; Teva, Czech Republic; Teva, Germany; Teva, Denmark; Teva, Israel; Teva, Luxembourg; Teva, Netherlands; Teva, Norway; Teva, Slovenia; Teva Neuroscience, Canada; Teva Neuroscience, United States; Teva Pharmaceuticals, United Kingdom



• Elbrus
  Roemmers, Argentina

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.